Background: Sarcopenia is a prognostic factor for mortality in digestive surgery. However, the correlation between preoperative cardiopulmonary function and sarcopenia in patients undergoing hepatectomy for hepatocellular carcinoma (HCC) remains unclear. Methods: The present study investigated the impact of preoperative sarcopenia on cardiopulmonary function in 402 patients who underwent first hepatectomy for HCC between April 2005 and April 2015. The quantity and quality of skeletal muscle were evaluated using psoas muscle index (PMI) and intramuscular adipose tissue content (IMAC), respectively, as determined from preoperative computed tomography imaging. Correlations between preoperative cardiopulmonary function and sarcopenic factors (PMI and IMAC) were evaluated. Results: No significant correlations were found between left ventricular ejection fraction and the two sarcopenic factors. On the other hand, preoperative vital capacity (VC) and forced expiratory volume in 1 s (FEV 1 ) correlated significantly with PMI (p < 0.001 each) in males and with IMAC (p < 0.001 each) in females. Moreover, VC and FEV 1 in the preoperative low PMI (p < 0.001 each) and high IMAC (p = 0.002 and p < 0.001, respectively) groups were significantly lower than in the normal group in males. In females, VC and FEV 1 were significantly lower in the preoperative high IMAC group than in the normal group (p < 0.001 each). Conclusion: Preoperative low muscle mass in males and low muscle quality in males and females were significantly associated with pulmonary dysfunction.
Introduction
Sarcopenia was initially described as an age-related decrease in muscle mass [1] and is currently considered as a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength due to various causes. The definition of sarcopenia is now proposed to comprise low muscle mass and impaired muscular function [2, 3] . Sarcopenia is thus not only a condition affecting the elderly and can be observed at any age as a result of inflammatory conditions (including malignancies), malnutrition, and disuse. We have so far reported the negative impacts of preoperative sarcopenia on outcomes after living donor liver transplantation [4, 5] , hepatocellular carcinoma (HCC) [6, 7] , extrahepatic biliary malignancies [8] , and pancreatic cancer [9] . Various lines of evidence have also shown that sarcopenia is predictive of mortality in various diseases and after various surgeries [10] [11] [12] [13] . Among them, HCC is the sixth most common human cancer and the third most common cause of cancerrelated death [14] . Hepatectomy plays an important role in the treatment of HCC [15] . However, HCC patients with insufficient cardiopulmonary function cannot undergo hepatectomy.
A previous study demonstrated that among patients with chronic heart failure (CHF), patients with muscle wasting showed significantly lower left ventricular ejection fraction (EF) than patients without muscle wasting [16] . Moreover, Moon et al. [17] revealed an association between low muscle mass and pulmonary function in healthy Korean men and women ≥65 years old.
We previously reported the impact of sarcopenia and pulmonary dysfunction in living donor liver transplantation and the impact of pulmonary dysfunction in patients undergoing living donor liver transplantation [18] . Ezaki et al. [19] classified 139 Japanese patients with HCC undergoing hepatectomy into three groups according to age, and revealed that there was a statistically marked decline in the preoperative cardiac and pulmonary function in the group aged >66 years. Although they reported that there was no significant difference among the three groups in postoperative complications, mortality, and survival, they did not directly discuss the impact of pulmonary dysfunction in HCC patients. There has been no report directly discussing the impact of pulmonary dysfunction in HCC patients. Moreover, the impact of sarcopenia on cardiopulmonary function in patients undergoing digestive surgery, particularly patients with HCC undergoing hepatectomy, remains unclear. The present study investigated the correlations between preoperative cardiopulmonary function and sarcopenic parameters such as muscle mass and muscle quality in patients undergoing hepatectomy for HCC.
Patients and Methods

Patients and Data Collection
Between April 2005 and April 2015, a total of 572 patients underwent hepatectomy for HCC at Kyoto University Hospital. Seventy-two patients who did not undergo preoperative plain computed tomography (CT) at the level of the third lumbar vertebra were excluded from this study. Another 12 patients who underwent neither preoperative echocardiography nor preoperative spirometry in our hospital and 86 patients who underwent hepatectomy more than twice were excluded as well. As a result, 402 patients (325 men, 77 women) with results of echocardiography or preoperative spirometry data were registered in this study.
Data of preoperative blood examinations, including complete blood count, serum biochemistry, tumor marker, and indocyanine green retention test at 15 min, were collected. A pathological examination was performed for evaluating tumor size, tumor number, vascular invasion, tumor differentiation, and background liver in accordance with the rules of the Liver Cancer Study Group of Japan.
Echocardiography was performed in 82 patients (63 men, 19 women) and spirometry in 399 patients (323 men, 76 women). Seventy-nine patients (61 men, 18 women) underwent both echocardiography and spirometry. Echocardiography alone was performed in 3 patients (2 men, 1 woman) and spirometry alone in 320 patients (262 men, 58 women). Cardiac functions such as left ventricular EF were measured from preoperative echocardiography. Pulmonary functions such as vital capacity (VC), percentage of predicted VC (%VC), forced expiratory volume in 1 s (FEV 1 ), and percentage of predicted FEV 1 (%FEV 1 ) were determined from spirometry. We defined restrictive ventilatory impairment as %VC <80% and obstructive ventilatory impairment as %FEV 1 <70% of forced VC (FVC), with combined ventilatory impairment then defined as the presence of both restrictive and obstructive ventilatory impairment. All preoperative CT imaging was performed using a multidetector CT scanner (Aquilion 64; Toshiba Medical Systems, Otawara, Japan).
Image Analysis
The quantity of skeletal muscle was indicated by the psoas muscle index (PMI). The quality of skeletal muscle was indicated by the intramuscular adipose tissue content (IMAC). PMI and IMAC were measured from preoperative CT images at the level of the third lumbar vertebra for all patients (Fig. 1) . Cross-sectional areas of bilateral psoas muscles were measured by manual tracing (Fig. 1a) , and PMI was calculated by normalizing this cross-sectional area of bilateral psoas muscles to the square of the patient's height in meters. IMAC was calculated as previously described by Kitajima et al. [20] : IMAC = mean CT attenuation value (in Hounsfield units) for region of interest in multifidus muscle / mean CT attenuation value for region of interest in subcutaneous fat.
Subfascial muscular tissue in the multifidus muscle on preoperative cross-sectional plain CT at the level of the third lumbar vertebra was precisely traced, and CT attenuation values were measured using the AquariusNET server (TeraRecon, San Mateo, CA, USA) (Fig. 1b) . CT attenuation values of subcutaneous fat were measured for four circular regions of interest in subcutaneous fat away from major vessels (Fig. 1c) .
Analyzed Parameters
We analyzed correlations among PMI or IMAC and preoperative cardiopulmonary parameters including EF, VC, %VC, FEV 1 , and %FEV 1 . Correlations of PMI and IMAC with preoperative pulmonary functions were examined. We then examined the relationship between preoperative pulmonary function and degrees of depletion of both skeletal muscle mass and quality. We previously reported sex-specific cutoffs for low PMI of 6.36 cm 2 /m 2 for men and 3.92 cm 2 /m 2 for women (mean -2 standard deviations [SDs]) [21, 22] . Based on these donor cutoffs (i.e., cutoffs for healthy young adults), we divided the 399 patients who had undergone spirometry into two groups: a preoperative low PMI group showing low muscle mass (mean below -2 SDs), n = 133 (122 men, 11 women), and a normal PMI group (mean equal to or above -2 SDs), n = 266 (201 men, 65 women).
As sex-specific cutoffs for low IMAC, we again applied donor cutoffs, using high IMAC cutoffs of -0.358 for men and -0.229 for women (mean + 2 SDs) [22] . Based on these values, we divided the 399 patients who had undergone spirometry into another two groups: a preoperative high IMAC group showing low muscle quality (mean below +2 SDs), n = 221 (174 men, 47 women), and a normal IMAC group (mean equal to or above +2 SDs), n = 178 (149 men, 29 women). Multiple comparisons of survival curves according preoperative pulmonary function and risk factors for poor survival were then performed.
Statistical Analysis
Data are presented as mean ± SD for continuous variables unless otherwise indicated. Continuous variables were analyzed nonparametrically using the Mann-Whitney U test. Categorical variables were compared using the χ 2 test or the Fisher exact test, as appropriate. Cumulative overall survival rates were calculated using the Kaplan-Meier method and differences between curves were evaluated using the Wilcoxon test. In survival time analysis according to group, pairwise comparison of each level of group variable was performed using the Holm method and the p value from the Wilcoxon test, and adjusted p values were determined. p values <0.05 were considered to indicate statistical significance. All statistical data were generated using the JMP Pro version 12 software (SAS Institute, Cary, NC, USA).
Results
Patient Characteristics
The clinicopathological characteristics of the 402 patients are shown in Table 1 
Correlations between Preoperative EF and Sarcopenic Factors
For males, EF did not correlate significantly with PMI (r = -0.190, p = 0.135; online suppl. 
Correlations between PMI and Preoperative Pulmonary Parameters
Correlations between IMAC and Preoperative Pulmonary Parameters
For males, a significant but weak negative correlation was observed between IMAC and FEV 1 (r = 0.203, p < 0.001; Fig. 3c ), although no other preoperative pulmonary parameters 
Analysis according to Preoperative PMI Status
In males, VC, %VC, and FEV 1 were significantly lower in the preoperative low PMI group than in the normal PMI group (p < 0.001, p = 0.004, and p < 0.001, respectively) ( Table 2 ). In females, preoperative pulmonary functions did not significantly differ between the low PMI and the normal PMI group (Table 2) .
Analysis according to Preoperative IMAC Status
In males, VC and FEV 1 were significantly lower in the preoperative high IMAC group than in the normal IMAC group (p = 0.002 and p < 0.001, respectively) ( Table 2 ). In females, VC and FEV 1 were also significantly lower in the high IMAC group than in the normal IMAC group (p < 0.001 and p < 0.001, respectively) ( Table 2) .
Overall Survival Rate after Hepatectomy according to Preoperative Pulmonary Function
The overall survival rate after hepatectomy was significantly lower in patients with preoperative restrictive ventilatory impairment (n = 21; 20 men, 1 woman) compared with patients with preoperative normal pulmonary function (n = 290; 225 men, 65 women; p = 0.021) (Fig. 4) .
Risk Factors for Poor Survival in Patients Undergoing Hepatectomy
The results of uni-and multivariate analyses of overall survival in patients undergoing hepatectomy for HCC are shown in Table 3 . In univariate analysis, previous treatment for HCC, low platelet count (<10 × 10 4 /mm 3 ), high α-fetoprotein (≥20 ng/dL), tumor size (≥5.0 cm), number of tumors (solitary), tumor differentiation (poor), TNM stage (stage III or IV), surgical procedure (≥lobectomy), operative blood loss (≥500 g), preoperative high IMAC, and restrictive ventilatory impairment were identified as significant poor risk factors among patients undergoing hepatectomy.
Multivariate analysis revealed liver histology (liver fibrosis or cirrhosis), tumor size (≥5.0 cm), TNM stage (III or IV), and preoperative high IMAC as independent risk factors, but preoperative restrictive ventilatory impairment was not a significant risk factor even though the overall survival of patients with preoperative restrictive ventilatory impairment was significantly lower than that of patients with normal pulmonary function.
Discussion
To the best of our knowledge, this retrospective study of 402 patients is the first to investigate the relationship between preoperative cardiopulmonary function and sarcopenic factors in patients undergoing first hepatectomy for HCC. In the present study, low pulmonary function was closely associated with sarcopenic factors such as PMI and IMAC. Pulmonary function progressively decreases after 20-25 years of age [23] . With age, parenchymal lung tissue is lost, chest wall compliance decreases, and intercostal muscle mass and force are reduced as the elastic elements in the lungs degenerate [24] . Moon et al. [17] revealed an association between low muscle mass and pulmonary function in healthy Korean men and women aged ≥65 years. Moreover, Jeon et al. [25] showed that low pulmonary function, as represented by decreased FEV 1 or VC, was associated with low muscle mass in older adults. Findings from the present study of patients undergoing hepatectomy for HCC are in line with those reports. In males, VC correlated significantly with PMI (Fig. 2a) . Moreover, FEV 1 significantly correlated with both PMI (Fig. 2c) and IMAC (Fig. 3c) . In contrast, in females, PMI did not correlate with either %VC or VC, while IMAC correlated significantly with both VC (Fig. 3e) and %VC (Fig. 3f) . FEV 1 only showed a significant correlation with IMAC in females (Fig. 3g) . When patients were divided into two groups by PMI using each sex-specific cutoff, most analyses showed significant differences between low PMI and pulmonary functions in males. In contrast, no significant correlations were found in females. As for IMAC, similar significant differences were found in both males and females. We speculate that this difference was related to the lower skeletal muscle mass in females than in males. Moreover, the range of distribution of PMI was narrower in females than in males. This reduction in differences in PMI might have resulted in the lack of significant correlation between PMI and pulmonary function among females. On the other hand, IMAC as a parameter of muscle quality showed no differences in quantity or distribution between males and females. Significant close relationships were thus found between IMAC levels and pulmonary functions in both males and females.
This study showed the discrepancy in the result between FEV 1 and %FEV 1 in males (Fig. 2) , except for %VC in men and the result between VC and %VC as well as FEV 1 and %FEV 1 (Fig. 3) , except for %VC in females. %VC is a derived value of VC, which is usually defined as VC of the patient divided by average VC in the population for any person of similar age, sex, (continued) and height. %FEV 1 is defined as FEV 1 /FVC ratio. Therefore, these predicted values or calculated ratios, %VC or %FEV 1 , might not reflect more directly than absolute values as VC or FEV 1 .
In contrast, cardiac function did not correlate with any sarcopenic factors. Lin et al. [26] revealed that age-related cardiac sarcopenia occurs in mice and that left ventricular remodeling due to increased end-diastolic pressure could be one mechanism underlying age-related left ventricular dysfunction. Fülster et al. [16] reported that in patients with CHF, patients with muscle wasting showed significantly lower left ventricular EF than patients without muscle wasting. However, the present study found no significant relationship between EF and sarcopenic factors. This may have been because this study included 175 patients >70 years old who could undergo hepatectomy. Patients with heart diseases such as CHF are usually excluded as candidates for hepatectomy because such patients often cannot tolerate an operation under general anesthesia. Such selection biases in the present study might have contributed to the lack of a significant relationship between EF and sarcopenic factors. Moreover, to date no evidence has indicated an association between sarcopenia and cardiac function in healthy elderly individuals. Under extreme conditions such as CHF, sarcopenia might influence cardiac function.
The overall survival rate was significantly lower in patients with preoperative pulmonary restrictive impairment than in those with normal preoperative pulmonary function. Although restrictive impairment was a poor risk factor in univariate but not multivariate analysis, preoperative pulmonary dysfunction could increase the incidence of postoperative morbidities such as atelectasis or pneumonia, leading to worse survival.
Several reports have shown the effectiveness of preoperative rehabilitation in decreasing postoperative complication in patients with esophageal [27] , colorectal [28] , and lung cancers [29] . Koya et al. [30] demonstrated that therapeutic exercise improved cardiopulmonary function evaluated by a 6-min walking test in HCC patients.
We previously reported the impact of nutritional therapy on prognosis in patients undergoing living donor liver transplantation [4] . Taken together, perioperative nutrition therapy and rehabilitation would be important for patients with preoperative sarcopenia or pulmonary dysfunction undergoing hepatectomy for HCC. We are planning to perform perioperative intervention therapy with respiratory rehabilitation and nutritional therapy using branchedchain amino acids.
Several limitations must be considered for the present study. First, this was a retrospective study conducted in a single institution. Whether pulmonary dysfunction was the cause or result of sarcopenia remains unclear. We speculate that both causal relationships are possible. Preexisting sarcopenia might induce pulmonary dysfunction in some patients, and sarcopenia might develop as a result of pulmonary dysfunction in some patients. We are therefore conducting a prospective analysis to clarify the direction of causality between sarcopenia and lung function by measuring these parameters at various time points before and after hepatectomy. Second, the Asian and European Working Group on Sarcopenia in Older People proposed the inclusion of not only low muscle mass, but also low muscle function in the definition of sarcopenia. However, the present study did not estimate low muscle function (i.e., strength or performance). We are therefore now prospectively investigating the relationship between muscle function and cardiopulmonary functions. Third, selection bias was seen for patient inclusion in the study group. As mentioned above, hepatectomy is not usually performed in patients with CHF or severe pulmonary dysfunction, since such patients are at an unacceptable risk of not tolerating the surgery. Patients with severe cardiopulmonary dysfunction might thus have tended to be excluded from the present study.
In conclusion, the present results show that preoperative low muscle mass and low muscle quality are closely related to pulmonary dysfunction in patients undergoing hepa-
